| Ident. | Authors (with country if any) | Title |
|---|
| 000038 (2019) |
Xavier Saelens [Belgique] | The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines |
| 000089 (2019) |
Jiantao Zhang [États-Unis] ; Yanmei Hu [États-Unis] ; Rami Musharrafieh [États-Unis] ; Hang Yin [États-Unis] ; Jun Wang [États-Unis] | Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development |
| 000095 (2019) |
Jiun-Jie Shie [Taïwan] ; Jim-Min Fang [Taïwan] | Development of effective anti-influenza drugs: congeners and conjugates – a review |
| 000096 (2019) |
Seyed Davoud Jazayeri ; Chit Laa Poh | Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins |
| 000128 (2018-03) |
V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France] | Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study |
| 000173 (2018) |
Arun Kumar [Italie, Suède] ; Trine Sundebo Meldgaard [Italie, Danemark] ; Sylvie Bertholet [Italie, États-Unis] | Novel Platforms for the Development of a Universal Influenza Vaccine |
| 000219 (2018) |
Rory D. De Vries ; Sander Herfst ; Mathilde Richard | Avian Influenza A Virus Pandemic Preparedness and Vaccine Development |
| 000234 (2017-12) |
Ülkü Anik [Turquie] ; Yudum Tepeli [Turquie] ; Maher Sayhi [Tunisie] ; Jihene Nsiri [Tunisie] ; Mohamed Diouani [Tunisie] | Towards the Electrochemical Diagnostic of Influenza Virus: Development of Graphene-Au Hybrid Nanocomposite Modified Influenza Virus Biosensor Based on Neuraminidase Activity |
| 000238 (2017-12) |
Angela Filomena [Allemagne] ; Frank Pessler [Allemagne] ; Manas Akmatov [Allemagne] ; Gérard Krause [Allemagne] ; Darragh Duffy ; Barbara G Rtner [Allemagne] ; Markus Gerhard [Allemagne] ; Matthew Albert ; Thomas Joos [Allemagne] ; Nicole Schneiderhan-Marra [Allemagne] | Development of a Bead-Based Multiplex Assay for the Analysis of the Serological Response against the Six Pathogens HAV, HBV, HCV, CMV, T. gondii, and H. pylori |
| 000312 (2017) |
Wandi Zhu ; Chao Wang ; Bao-Zhong Wang | From Variation of Influenza Viral Proteins to Vaccine Development |
| 000332 (2017) |
Andrey Komissarov [Russie] ; Artem Fadeev [Russie] ; Anna Kosheleva [Russie] ; Kseniya Sintsova [Russie] ; Mikhail Grudinin [Russie] | Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses. |
| 000410 (2016) |
Aitor Nogales ; Luis Martínez-Sobrido | Reverse Genetics Approaches for the Development of Influenza Vaccines |
| 000504 (2015) |
Qiang Liu [République populaire de Chine] ; Yuan-Hong Zhou [République populaire de Chine] ; Zhan-Qiu Yang [République populaire de Chine] | The cytokine storm of severe influenza and development of immunomodulatory therapy |
| 000576 (2015) |
Callie Ridenour [États-Unis] ; Adam Johnson [États-Unis] ; Emily Winne [États-Unis] ; Jaber Hossain [États-Unis] ; Guaniri Mateu-Petit [États-Unis] ; Amanda Balish [États-Unis] ; Wanda Santana [États-Unis] ; Taejoong Kim [États-Unis] ; Charles Davis [États-Unis] ; Nancy J. Cox [États-Unis] ; John R. Barr [États-Unis] ; Ruben O. Donis [États-Unis] ; Julie Villanueva [États-Unis] ; Tracie L. Williams [États-Unis] ; Li-Mei Chen [États-Unis] | Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs |
| 000577 (2015) |
Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie] | Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. |
| 000578 (2015) |
Aitor Nogales ; Steven F. Baker ; William Domm ; Luis Martínez-Sobrido | Development and applications of single-cycle infectious Influenza A Virus (sciIAV) |
| 000629 (2014-08) |
Antoine Marçais [France] ; Julien Cherfils-Vicini [France] ; Charlotte Viant [France] ; Sophie Degouve [France] ; Sébastien Viel [France] ; Aurore Fenis [France] ; Jessica Rabilloud [France] ; Katia Mayol [France] ; Armelle Tavares [France] ; Jacques Bienvenu [France] ; Yann-Gaël Gangloff [France] ; Eric Gilson [France] ; Eric Vivier [France] ; Thierry Walzer [France] | The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells |
| 000678 (2014) |
Mary Dawn T. Co ; Masanori Terajima ; Stephen J. Thomas ; Richard G. Jarman ; Kamonthip Rungrojcharoenkit ; Stefan Fernandez ; In-Kyu Yoon ; Darunee Buddhari ; John Cruz ; Francis A. Ennis | Relationship of Preexisting Influenza Hemagglutination Inhibition, Complement-Dependent Lytic, and Antibody-Dependent Cellular Cytotoxicity Antibodies to the Development of Clinical Illness in a Prospective Study of A(H1N1)pdm09 Influenza in Children |
| 000686 (2014) |
Madhu Khanna [Inde] ; Sachin Sharma [Inde] ; Binod Kumar [Inde] ; Roopali Rajput [Inde] | Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development |
| 000729 (2014) |
Darrell P. Chandler [États-Unis] ; Sara B. Griesemer [États-Unis] ; Christopher Knickerbocker [États-Unis] ; Julia B. Golova [États-Unis] ; Amine Lambarqui [États-Unis] ; Alexander N. Perov [États-Unis] ; Cynthia Zimmerman [États-Unis] ; Cory Wiles [États-Unis] ; George B. Rudy [États-Unis] ; Kirsten St. George [États-Unis] | Development and clinical testing of a simple, low-density gel element array for influenza identification, subtyping, and H275Y detection |
| 000730 (2014) |
Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie] | Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus |
